BIOLIFE SOLUTIONS INC's ticker is BLFS and the CUSIP is 09062W204. A total of 76 filers reported holding BIOLIFE SOLUTIONS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,216,468 | +276.6% | 88,086 | +916.2% | 0.01% | +200.0% |
| Q4 2021 | $323,000 | -12.0% | 8,668 | 0.0% | 0.00% | -25.0% |
| Q3 2021 | $367,000 | -4.9% | 8,668 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $386,000 | +18.8% | 8,668 | -3.9% | 0.00% | 0.0% |
| Q1 2021 | $325,000 | -9.7% | 9,018 | 0.0% | 0.00% | -20.0% |
| Q4 2020 | $360,000 | +16.9% | 9,018 | -15.2% | 0.01% | 0.0% |
| Q3 2020 | $308,000 | +77.0% | 10,639 | 0.0% | 0.01% | +25.0% |
| Q2 2020 | $174,000 | +51.3% | 10,639 | -12.0% | 0.00% | +33.3% |
| Q1 2020 | $115,000 | -49.1% | 12,089 | -13.3% | 0.00% | -50.0% |
| Q4 2019 | $226,000 | -6.2% | 13,945 | -3.8% | 0.01% | -14.3% |
| Q3 2019 | $241,000 | -2.0% | 14,495 | 0.0% | 0.01% | -12.5% |
| Q2 2019 | $246,000 | -5.0% | 14,495 | 0.0% | 0.01% | -11.1% |
| Q1 2019 | $259,000 | +48.9% | 14,495 | 0.0% | 0.01% | +28.6% |
| Q4 2018 | $174,000 | – | 14,495 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 7,566,292 | $171,982,000 | 7.71% |
| Gagnon Advisors, LLC | 205,968 | $4,682,000 | 2.16% |
| Ranger Investment Management | 1,300,407 | $29,558,000 | 1.87% |
| GAGNON SECURITIES LLC | 379,506 | $8,626,000 | 1.41% |
| Zweig-DiMenna Associates LLC | 376,550 | $8,559,000 | 1.14% |
| Meros Investment Management, LP | 48,504 | $1,102,000 | 0.87% |
| Mesirow Financial Investment Management, Inc. | 10,526 | $239,000 | 0.81% |
| Penbrook Management LLC | 48,615 | $1,105,000 | 0.72% |
| MOODY ALDRICH PARTNERS LLC | 220,680 | $5,016,000 | 0.70% |
| GENEVA CAPITAL MANAGEMENT LLC | 1,456,656 | $33,110,000 | 0.64% |